Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response.
Splinter, T A
Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response. [electronic resource] - Progress in clinical and biological research 1988 - 579-90 p. digital
Publication Type: Journal Article
0361-7742
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Transitional Cell--drug therapy
Cisplatin--administration & dosage
Combined Modality Therapy
Drug Evaluation
Humans
Methotrexate--administration & dosage
Preoperative Care
Urinary Bladder Neoplasms--drug therapy
Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response. [electronic resource] - Progress in clinical and biological research 1988 - 579-90 p. digital
Publication Type: Journal Article
0361-7742
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Transitional Cell--drug therapy
Cisplatin--administration & dosage
Combined Modality Therapy
Drug Evaluation
Humans
Methotrexate--administration & dosage
Preoperative Care
Urinary Bladder Neoplasms--drug therapy